Back to search
FDAFDA · Food and drugs·Recall number D-0739-2016

Morphine Sulfate 0.5 mg/ml/Baclofen 1000 mcg/ml/, vol. 20 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA

Published March 16, 2016 · Recall initiated: February 4, 2016

Summary

FDA records drug Class II recall D-0739-2016, published March 16, 2016 and initiated February 4, 2016. Recalling firm: Hartley Medical Center Pharmacy, Incorporated; Status: Terminated; Reported quantity: 1 syringe; Lot: BUD: 5/3/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hartley Medical Center Pharmacy, Incorporated
Distributor
Nationwide. No foreign distribution.
Lot
BUD: 5/3/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Morphine Sulfate 0.5 mg/ml/Baclofen 1000 mcg/ml/, vol. 20 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA recalled?

Yes. FDA published recall D-0739-2016 on March 16, 2016. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone